About

As a hepatologist and transplant provider at NYU Langone, AnnMarie Liapakis is deeply committed to providing comprehensive and compassionate care to her patients. Her philosophy of care centers on treating the whole person, not just the specific liver disease, and she is passionate about dispelling myths and misinformation surrounding liver conditions. She specializes in managing a wide range of liver diseases, including advanced liver disease and liver transplantation, and has extensive experience in understanding how liver disease can affect other organ systems. Dr. Liapakis serves as the medical director of living donor liver transplantation at the NYU Langone Transplant Institute, where she works to maximize transplant opportunities and ensure the safety of living liver donors. Throughout her career, she has been actively involved in creating educational materials and advocating for policies that support patients with liver disease, working with organizations such as the American Liver Foundation and Donate Life Connecticut. Her dedication to patient education and advocacy has been recognized with honors such as the Physician of the Year award from the American Liver Foundation.

Research topics

• Political Science
• Surgery
• Medicine
• Public relations
• Engineering ethics

Selected publications

• The Liver in Systemic Disease

  Clinics in Liver Disease · 2025-05-26

  editorial1st authorCorresponding
  PublisherDOI

• Establishing best practices for obesity and metabolic syndrome in liver transplantation: Insights from a modified Delphi-based controversies conference

  American Journal of Transplantation · 2025-10-22 · 1 citations

  article
  PublisherDOI

• AASLD AST Practice Guideline on adult liver transplantation: Candidate evaluation

  Hepatology · 2025-12-17 · 5 citations

  articleOpen access

  BACKGROUND AND AIMS: Liver transplant is a specialized treatment for a spectrum of indications that use a scarce resource. Transplant is guided by principles of justice, equity and benefit with a constant conflict between competing interests. Organs are a national resource with a goal of equitable distribution across sites. An AASLD guideline for the evaluation and selection of appropriate transplant candidates has been available since 2005. METHODS: A multidisciplinary writing group of liver transplant experts and a librarian convened over 24 months. The writing group reviewed the literature, generated guideline recommendations and rated the level of evidence for each recommendation based on the Oxford Center for Evidence-Based Medicine. The group categorized the strength of recommendations based on the level of evidence, risk-benefit ratio, and patient preferences. CONCLUSIONS: Liver transplant is a lifesaving procedure that should be offered to selected patients with clear indications and a reasonable prospect of benefit. The evaluation is designed to identify those in need, to outline hurdles to a successful outcome, and to develop an effective transplant plan. The goal of this document is to provide a template for this process.

  PublisherOA PDFDOI

• Obesogenic Medications and Increased Risk of Metabolic Liver Disease: Is there an avoidable iatrogenic contribution to metabolic- associated liver failure?

  American Journal of Transplantation · 2025-01-01

  articleOpen access
  PublisherOA PDFDOI

• Barriers to Expanding Living Donor Paired Exchange in the United States: A Delphi Survey of Operational, Financial and Ethical Challenges

  American Journal of Transplantation · 2025-08-01

  articleSenior author
  PublisherDOI

• The Liver in Systemic Disease

  Clinics in Liver Disease · 2025-07-15

  article1st authorCorresponding
  PublisherDOI

• Engaging Transplant Professionals with a Novel Educational Model Using Social Media Visuals

  American Journal of Transplantation · 2025-08-01

  article
  PublisherDOI

• Multimedia Approach To Living Donation Education for Transplant Professionals: Building a Professional Society Multimedia Work Group

  Current Transplantation Reports · 2025-07-12

  articleOpen access
  PublisherOA PDFDOI

• Long-term considerations following living liver donation—Guidelines from the 2025 ILTS-iLDLT consensus conference on living liver donor safety

  Liver Transplantation · 2025-12-18 · 2 citations

  articleOpen access

  Living liver donation is a critical component for addressing organ shortage and improving outcomes for patients with end-stage liver disease. As the prevalence of living donor liver transplantation (LDLT) increases worldwide, understanding and optimizing long-term donor health is paramount. The 2025 International Liver Transplantation Society and International Living Donor Liver Transplantation Society (ILTS-iLDLT) Consensus Conference convened experts in the field of liver transplantation to establish evidence-based guidelines focused on the long-term medical, psychological, and social considerations following living liver donation. The aim of this working group was to integrate current evidence and expert consensus on donor follow-up protocols, risk assessment, and management strategies to promote long-term donor health, quality of life, and living liver donor programs globally to safeguard the welfare of this unique population.

  PublisherOA PDFDOI

• S2686 Characterization of Cirrhosis Prevalence and Disparities in Linkage to Care Among Underinsured Sexual and Gender Minorities in a Large Public Health System

  The American Journal of Gastroenterology · 2025-10-01

  articleSenior author

  Introduction: Sexual and gender minorities (SGM) are disproportionately affected by conditions that increase chronic liver disease risk, including viral hepatitis, alcohol use, diabetes, and obesity. However, data on cirrhosis prevalence among SGM is limited. This is the first study to describe cirrhosis prevalence, etiologies, and linkage to care in a predominantly Medicaid-insured SGM population. Methods: In our large, urban public hospital system, we identified adults with an International Classification of Diseases, Tenth Revision diagnosis of cirrhosis and self-reported sexual orientation and gender identity (SOGI) data from January 1, 2000 to May 1, 2025. Charts were reviewed to confirm cirrhosis (by imaging, elastography, or biopsy), determine etiology, and assess linkage to care defined as a gastroenterology or hepatology clinic visit in the last year. These outcomes were analyzed with descriptive statistics and compared to a non-SGM straight, cisgender cohort. Results: Of 7,451,107 adult patients in the system during the study period, 758,840 (10.2%) had SOGI data. 44,507 (5.9% of patients with SOGI data) identified as SGM. Ninety-five SGM and 2,506 non-SGM patients had cirrhosis. The SGM group was younger (mean age 53.2 vs 60.3 years, P < 0.05). Both cohorts were predominantly Hispanic (53.7% SGM vs 57.5% non-SGM), male sex at birth (77.9% vs 68.9%), and Medicaid-enrolled (62.1% vs 55.7%), Gay (47.4%) and cisgender men (62.1%) were the most represented identities in the SGM cohort. SGM had a lower cirrhosis prevalence (213 per 100,000; 95% CI 175–261) than non-SGM (351 per 100,000; CI 337–365). Leading causes in SGM were alcohol (54.7%, CI 44.7–64.4%) and viral hepatitis (26.3%, CI 18.5–36.0%), similar to non-SGM. Linkage to liver specialty care was low in both groups (37.9% SGM, CI 28.8–47.9%; 36.7% non-SGM, CI 34.8–38.6%). Conclusion: Despite lower observed cirrhosis prevalence in SGM, the figure is likely underestimated. Only 10% of patients had SOGI data, underscoring the need for expanded SOGI collection. This study is a critical step in understanding cirrhosis among SGM individuals with intersecting minority identities (SGM, Hispanic, underinsured) that impact access to care. Two-thirds of SGM patients with cirrhosis are not linked to specialty care. Future work includes expanding SOGI collection and developing targeted pathways to close care gaps. The younger age in SGM with cirrhosis also warrants further study, as it may reflect earlier exposure to risk factors leading to accelerated disease progression.

  PublisherDOI

Frequent coauthors

• Raffi Karagozian

  Tufts University

  16 shared

• Michael Cho

  Harvard University

  16 shared

• Mena Bakhit

  16 shared

• Thomas R. McCarty

  16 shared

• Basile Njei

  Brookdale University Hospital and Medical Center

  16 shared

• Sunhee Park

  16 shared

• Joseph K. Lim

  VA Connecticut Healthcare System

  15 shared

• Benjamin Samstein

  13 shared

Awards & honors

• Physician of the Year award from the American Liver Foundati…